Cargando…
Proteomic biomarkers for survival in systemic sclerosis-associated pulmonary hypertension
BACKGROUND: Interstitial lung disease (ILD) and pulmonary hypertension (PH) represent the major causes of mortality in systemic sclerosis (SSc). Patients with systemic sclerosis and combined PH and ILD (SSc-PH-ILD) generally have a poor prognosis. Predictors of survival and of potential benefit of t...
Autores principales: | Mismetti, Valentine, Delavenne, Xavier, Montani, David, Bezzeghoud, Souad, Delezay, Olivier, Hodin, Sophie, Launay, David, Marchand-Adam, Sylvain, Nunes, Hilario, Ollier, Edouard, Reynaud-Gaubert, Martine, Pastre, Jean, Traclet, Julie, Quetant, Sébastien, Zeghmar, Sabrina, Bertoletti, Laurent, Cottin, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629050/ https://www.ncbi.nlm.nih.gov/pubmed/37936223 http://dx.doi.org/10.1186/s12931-023-02578-0 |
Ejemplares similares
-
Pulmonary hypertension in chronic lung diseases: comparison to other pulmonary hypertension groups
por: Chebib, Nader, et al.
Publicado: (2018) -
A new paradigm for personalized prophylaxis for patients with severe haemophilia A
por: Delavenne, Xavier, et al.
Publicado: (2020) -
Population pharmacokinetic model of cefazolin in total hip arthroplasty
por: Lanoiselée, J., et al.
Publicado: (2021) -
Rituximab for auto-immune alveolar proteinosis, a real life cohort study
por: Soyez, Berenice, et al.
Publicado: (2018) -
Obstructive Sleep Apnea, Hypercoagulability, and the Blood–Brain Barrier
por: Zolotoff, Cindy, et al.
Publicado: (2021)